PMID: 9191666May 1, 1997Paper

Pulmonary hypertension and systemic vasoconstriction may offset the benefits of acellular hemoglobin blood substitutes

The Journal of Trauma
L F de FigueiredoG C Kramer

Abstract

We tested the hypothesis that the pharmacologic properties of a small volume of alpha alpha-cross-linked hemoglobin (alpha alpha Hb) could effectively resuscitate pigs subjected to hemorrhage. Fourteen pigs hemorrhaged to a mean arterial pressure (MAP) of 40 mm Hg for 60 minutes were treated with a 4-mL/kg 2-minute infusion of 10 g/dL alpha alpha Hb or 7 g/dL human serum albumin, an oncotically matched control solution. The removal of blood (17 +/- 1.5 mL/kg) caused the typical physiologic responses to hemorrhagic hypovolemia. Infusion of alpha alpha Hb restored mean arterial pressure and coronary perfusion pressure, but cardiac output and mixed venous O2 saturation did not improve significantly. Pulmonary arterial pressure and pulmonary vascular resistance increased markedly and were higher than baseline levels after alpha alpha Hb. Infusion of human serum albumin produced only minor hemodynamic changes. Brain blood flow did improve to baseline values after alpha alpha Hb, but was the only tissue to do so. In the human serum albumin group, superior mesenteric artery blood flow recovered to baseline values, whereas brain blood flow did not. Blood flows to other tissues were similar in both groups. Small-volume infusion of alpha...Continue Reading

References

Dec 28, 1992·Science·D E Koshland
Apr 1, 1991·Journal of Applied Physiology·J R HessR M Winslow
Dec 21, 1990·Science·R Pool
Jan 1, 1995·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·H W Kim, A G Greenburg
Nov 1, 1993·Journal of Applied Physiology·R Motterlini, V W Macdonald
Jan 1, 1994·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·S S KatsuyamaK Bradley
Jun 1, 1995·Annals of Medicine·E Moilanen, H Vapaatalo
Jul 1, 1995·Journal of Applied Physiology·R LeeG J Vlahakes
Jan 1, 1995·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·E DunlapK Burhop
Jan 1, 1994·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·D S MalcolmK Burhop
Apr 1, 1993·Journal of Applied Physiology·J R HessW W Brinkley
Jan 1, 1995·Advances in Pharmacology·C G Frostell, W M Zapol
Dec 1, 1995·The American Journal of Physiology·L Smith, J B Smith
Feb 1, 1996·Shock·M G MourelatosW R Law
May 1, 1996·Critical Care Medicine·G S HughesE E Jacobs
Sep 1, 1996·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·G MarchandK Burhop

❮ Previous
Next ❯

Citations

Mar 3, 2004·Free Radical Biology & Medicine·John S OlsonDouglas D Lemon
Mar 3, 2004·Free Radical Biology & Medicine·Mark T GladwinRakesh P Patel
Sep 11, 1999·Trends in Neurosciences·R J Miller, O Meucci
Jan 9, 2003·Journal of the American College of Surgeons·Ernest E Moore
May 12, 2001·Journal of Veterinary Pharmacology and Therapeutics·B DriessenR A Gunther
Aug 8, 2009·Antioxidants & Redox Signaling·Paul W Buehler, Felice D'Agnillo
Feb 13, 2003·Current Opinion in Hematology·Christopher D Reiter, Mark T Gladwin
Sep 2, 2005·Shock·Ernest E MooreAnirban Banerjee
Jan 31, 2009·Artificial Organs·Hiromi SakaiEishun Tsuchida
Oct 14, 1998·American Journal of Respiratory and Critical Care Medicine·R L ConhaimB A Harms
Jan 1, 1997·Critical Care : the Official Journal of the Critical Care Forum·L F FigueiredoG C Kramer
Oct 3, 2002·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Seong K LeeGeoffrey T Manley
Jan 5, 2002·The Surgical Clinics of North America·M OrlinskyM D Kerstein
Sep 24, 2004·Transfusion·Paul W Buehler, Abdu I Alayash
Mar 21, 2002·Artificial Organs·L F de FigueiredoM R e Silva
Mar 21, 2002·Artificial Organs·L F de FigueiredoG C Kramer
Oct 29, 2004·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·H W KimA G Greenburg
Nov 12, 2002·Nature Medicine·Christopher D ReiterMark T Gladwin
Jun 11, 1999·The American Journal of Physiology·S R FischerG C Kramer
Jul 12, 2017·Oxidative Medicine and Cellular Longevity·Ku Youn BaikByoungchoo Park
Feb 12, 2009·Bioconjugate Chemistry·Eishun TsuchidaKoichi Kobayashi
Feb 26, 1999·Annals of Emergency Medicine·E M Ketcham, C B Cairns

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.